Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma

Castellino, SM; Pei, QL; Parsons, SK; Hodgson, D; McCarten, K; Horton, T; Cho, SV; Wu, Y; Punnett, A; Dave, H; Henderson, TO; Hoppe, BS; Charpentier, AM; Keller, FG; Kelly, KM

Castellino, SM (通讯作者),Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr,ECC436, Atlanta, GA 30322 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2022; 387 (18): 1649

Abstract

Background In adults with advanced-stage Hodgkin's lymphoma, the CD30-directed antibody-drug conjugate brentuximab vedotin combined with multiagent ch......

Full Text Link